Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
Bertrand Routy(Centre Hospitalier de l’Université de Montréal), John Lenehan(Western University), Wilson H. Miller(Jewish General Hospital), Rahima Jamal(Centre Hospitalier de l’Université de Montréal), Meriem Messaoudene(Centre Hospitalier de l’Université de Montréal), Brendan A. Daisley(Western University), Cecilia Hes(Jewish General Hospital), Kait F. Al(Western University), Laura Martínez-Gili(St Mary's Hospital), Michal Punčochář(University of Trento), Scott Ernst(Western University), Diane Logan(Western University), Karl Bélanger(Centre Hospitalier de l’Université de Montréal), Khashayar Esfahani(Jewish General Hospital), Corentin Richard(Centre Hospitalier de l’Université de Montréal), Marina Ninkov(Western University), Gianmarco Piccinno(University of Trento), Federica Armanini(University of Trento), Federica Pinto(University of Trento), Mithunah Krishnamoorthy(Western University), René Figueredo(Western University), Paméla Thébault(Centre Hospitalier de l’Université de Montréal), Panteleimon G. Takis(Imperial College London), Jamie Magrill(McGill University), LeeAnn Ramsay(McGill University), Lisa Derosa(Inserm), Julian R. Marchesi(St Mary's Hospital), Seema Nair Parvathy(Western University), Arielle Elkrief(Centre Hospitalier de l’Université de Montréal), Ian R. Watson(McGill University), Réjean Lapointe(Centre Hospitalier de l’Université de Montréal), Nicola Segata(University of Trento), S. M. Mansour Haeryfar(Western University), Benjamin H. Mullish(Imperial College Healthcare NHS Trust), Michael Silverman(Western University), Jeremy P. Burton(Western University), Saman Maleki Vareki(Ontario Institute for Cancer Research)
Cited by 439